Author Question: A patient has been administered a cytotoxic antineoplastic agent. The patient is a 32-year-old ... (Read 62 times)

tfester · **on:** Jul 23, 2018

A patient has been administered a cytotoxic antineoplastic agent. The patient is a 32-year-old female. Which of the following is the most important instruction related to teratogenicity?

A) The medication will be completely eliminated 24 hours after the administration.
B) The patient should protect herself from infections and take Bactrim.
C) The patient should not become pregnant for several months.
D) The patient will not get pregnant due to the elimination of ova.

Question 2

A patient is being treated on the oncology unit and has developed worsening adverse effects over the past several days of chemotherapy. Administration of filgrastim (Neupogen) may aid in achieving what desired outcome?

A) Resolution of mucositis
B) Increased leukocytes
C) Increased platelet levels
D) Prevention of hemorrhagic cystitis

flexer1n1 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

C

Answer to Question 2

B
Feedback:
Severe neutropenia can be prevented or its extent and duration minimized by administering filgrastim or sargramostim to stimulate the bone marrow to produce leukocytes. Filgrastim does not address the patient's risk for bleeding.